# PeptideScanner evidence objects: Pramlintide

Every published version of the records placed with Pramlintide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/pramlintide.json. Selected public evidence only; not medical advice.

- Objects: 67
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct00206297-pramlintide-v1"></a>

## ClinicalTrials.gov record NCT00206297

> PeptideScanner retained ClinicalTrials.gov record NCT00206297 at 2026-07-30T21:36:16.909Z. Its registry update date was 2016-07-14, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct00206297-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-07-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00206297-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct00206297-pramlintide-v1
- Content SHA-256: `a1328ecbd1bde08a5fef6326ab146a12bb571929304abac215310bd184ea718c`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00206297 ([`ctg-observation-nct00206297-2016-07-14-c59b281c910a`](#source-ctg-observation-nct00206297-2016-07-14-c59b281c910a))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00206297 at 2026-07-30T21:36:16.909Z. Its registry update date was 2016-07-14, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00206297-2016-07-14-c59b281c910a`](#source-ctg-observation-nct00206297-2016-07-14-c59b281c910a))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00206297 at 2026-07-30T21:36:16.909Z. Its registry update date was 2016-07-14, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00206297-2016-07-14-c59b281c910a`](#source-ctg-observation-nct00206297-2016-07-14-c59b281c910a))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00206297-2016-07-14-c59b281c910a`](#source-ctg-observation-nct00206297-2016-07-14-c59b281c910a))

### Sources

<a id="source-ctg-observation-nct00206297-2016-07-14-c59b281c910a"></a>
- **ClinicalTrials.gov record NCT00206297 · retained source version 2016-07-14:c59b281c910abe2162816bd2024d03419c8488a73320e91c5170b1a2de7651f8** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00206297) (`ctg-observation-nct00206297-2016-07-14-c59b281c910a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00206297." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct00206297-pramlintide-v1 SHA-256: a1328ecbd1bde08a5fef6326ab146a12bb571929304abac215310bd184ea718c.

---

<a id="clinicaltrials-gov-nct00489645-pramlintide-v1"></a>

## ClinicalTrials.gov record NCT00489645

> PeptideScanner retained ClinicalTrials.gov record NCT00489645 at 2026-07-30T22:36:49.602Z. Its registry update date was 2008-01-16, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct00489645-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2008-01-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00489645-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct00489645-pramlintide-v1
- Content SHA-256: `03e17aa70cd59f81cabc3c5ac8ee4c592135d9b0c856c5cf2dabeaa6255e5e8a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00489645 ([`ctg-observation-nct00489645-2008-01-16-573f570afbb2`](#source-ctg-observation-nct00489645-2008-01-16-573f570afbb2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00489645 at 2026-07-30T22:36:49.602Z. Its registry update date was 2008-01-16, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00489645-2008-01-16-573f570afbb2`](#source-ctg-observation-nct00489645-2008-01-16-573f570afbb2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00489645 at 2026-07-30T22:36:49.602Z. Its registry update date was 2008-01-16, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00489645-2008-01-16-573f570afbb2`](#source-ctg-observation-nct00489645-2008-01-16-573f570afbb2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00489645-2008-01-16-573f570afbb2`](#source-ctg-observation-nct00489645-2008-01-16-573f570afbb2))

### Sources

<a id="source-ctg-observation-nct00489645-2008-01-16-573f570afbb2"></a>
- **ClinicalTrials.gov record NCT00489645 · retained source version 2008-01-16:573f570afbb249b1956e580574fd1434d7ec5bc02af2e6eb2468e74213a7c87a** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00489645) (`ctg-observation-nct00489645-2008-01-16-573f570afbb2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00489645." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct00489645-pramlintide-v1 SHA-256: 03e17aa70cd59f81cabc3c5ac8ee4c592135d9b0c856c5cf2dabeaa6255e5e8a.

---

<a id="clinicaltrials-gov-nct00690235-pramlintide-v1"></a>

## ClinicalTrials.gov record NCT00690235

> PeptideScanner retained ClinicalTrials.gov record NCT00690235 at 2026-07-30T21:07:45.452Z. Its registry update date was 2018-11-16, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct00690235-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00690235-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct00690235-pramlintide-v1
- Content SHA-256: `46c9fa999cd4160eb3319e81fdd7c66826eda104db7d99f1d2ccbffe65573dd3`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00690235 ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00690235 at 2026-07-30T21:07:45.452Z. Its registry update date was 2018-11-16, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00690235 at 2026-07-30T21:07:45.452Z. Its registry update date was 2018-11-16, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

### Sources

<a id="source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4"></a>
- **ClinicalTrials.gov record NCT00690235 · retained source version 2018-11-16:8e2070b489c431b3d9b4ac02c0dea8608296451d243fe28784f47aa59cf5a340** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00690235) (`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00690235." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct00690235-pramlintide-v1 SHA-256: 46c9fa999cd4160eb3319e81fdd7c66826eda104db7d99f1d2ccbffe65573dd3.

---

<a id="clinicaltrials-gov-nct01841359-pramlintide-v1"></a>

## ClinicalTrials.gov record NCT01841359

> PeptideScanner retained ClinicalTrials.gov record NCT01841359 at 2026-07-30T19:11:49.725Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct01841359-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-06-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01841359-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct01841359-pramlintide-v1
- Content SHA-256: `710f480a71818943fa23be7bd50d84fa5fc1cb50ee5069d8402b88868a906193`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01841359 ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01841359 at 2026-07-30T19:11:49.725Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01841359 at 2026-07-30T19:11:49.725Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`](#source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c))

### Sources

<a id="source-ctg-observation-nct01841359-2023-06-29-3d0df998d96c"></a>
- **ClinicalTrials.gov record NCT01841359 · retained source version 2023-06-29:3d0df998d96cd592ddfaec977b4f372b717cf9572637d643da8a39fc2d05e3fc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01841359) (`ctg-observation-nct01841359-2023-06-29-3d0df998d96c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01841359." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct01841359-pramlintide-v1 SHA-256: 710f480a71818943fa23be7bd50d84fa5fc1cb50ee5069d8402b88868a906193.

---

<a id="clinicaltrials-gov-nct05199714-pramlintide-v1"></a>

## ClinicalTrials.gov record NCT05199714

> PeptideScanner retained ClinicalTrials.gov record NCT05199714 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-25, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct05199714-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-10-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05199714-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct05199714-pramlintide-v1
- Content SHA-256: `b2519aa2096200f9f1ebbfa93cf795d1bf404f2a6058e5de299d1541c742aec8`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05199714 ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05199714 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-25, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05199714 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-25, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`](#source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3))

### Sources

<a id="source-ctg-observation-nct05199714-2023-10-25-64a2c7712ab3"></a>
- **ClinicalTrials.gov record NCT05199714 · retained source version 2023-10-25:64a2c7712ab351461209406942acc1dddf6c7f48ff3796e49c72afaec0bca351** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05199714) (`ctg-observation-nct05199714-2023-10-25-64a2c7712ab3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05199714." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#clinicaltrials-gov-nct05199714-pramlintide-v1 SHA-256: b2519aa2096200f9f1ebbfa93cf795d1bf404f2a6058e5de299d1541c742aec8.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-v1"></a>

## Pramlintide DailyMed SPL version 11

> DailyMed lists Structured Product Labeling version 11 for the reviewed Pramlintide label family with a published date of 2018-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11:v1`
- Evidence domain: Regulatory
- Date in source: 2018-11-14
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-v1
- Content SHA-256: `8f0ac8d3b163ed9648912850ae7affafe395a996674c3c126e352ae4cbbe7df4`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 11 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history))

#### Summary

DailyMed lists Structured Product Labeling version 11 for the reviewed Pramlintide label family with a published date of 2018-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 11 for the reviewed Pramlintide label family with a published date of 2018-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 11 · published 2018-11-14 · retained ZIP SHA-256 ae08ad3fa63ddd6bc50c10282de9c2673b7963eea8589072f22a69ddad20c0df** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=11) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 11." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v11-v1 SHA-256: 8f0ac8d3b163ed9648912850ae7affafe395a996674c3c126e352ae4cbbe7df4.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-v1"></a>

## Pramlintide DailyMed SPL version 12

> DailyMed lists Structured Product Labeling version 12 for the reviewed Pramlintide label family with a published date of 2019-12-24. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12:v1`
- Evidence domain: Regulatory
- Date in source: 2019-12-24
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-v1
- Content SHA-256: `c2ee66d1bfe91085cb3ae9218b396110f0559209cf26bbc223457c06bd5eb062`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 12 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history))

#### Summary

DailyMed lists Structured Product Labeling version 12 for the reviewed Pramlintide label family with a published date of 2019-12-24. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 12 for the reviewed Pramlintide label family with a published date of 2019-12-24. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 12 · published 2019-12-24 · retained ZIP SHA-256 15f822427e18715d1cee345e1903844a45d74f8e7f239db73b59edf4343642bd** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=12) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 12." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v12-v1 SHA-256: c2ee66d1bfe91085cb3ae9218b396110f0559209cf26bbc223457c06bd5eb062.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-v1"></a>

## Pramlintide DailyMed SPL version 13

> DailyMed lists Structured Product Labeling version 13 for the reviewed Pramlintide label family with a published date of 2022-10-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13:v1`
- Evidence domain: Regulatory
- Date in source: 2022-10-21
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-v1
- Content SHA-256: `fbb21f21248a071d381d04aa3da687bc91c3e1c1af09909a363971d5d45a6600`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 13 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history))

#### Summary

DailyMed lists Structured Product Labeling version 13 for the reviewed Pramlintide label family with a published date of 2022-10-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 13 for the reviewed Pramlintide label family with a published date of 2022-10-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 13 · published 2022-10-21 · retained ZIP SHA-256 d852564b92b0fc2c0b12c8a3db9340279ef216904b9aa4468e9ad7ea5c6aaaea** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=13) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 13." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v13-v1 SHA-256: fbb21f21248a071d381d04aa3da687bc91c3e1c1af09909a363971d5d45a6600.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-v1"></a>

## Pramlintide DailyMed SPL version 14

> DailyMed lists Structured Product Labeling version 14 for the reviewed Pramlintide label family with a published date of 2023-02-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14:v1`
- Evidence domain: Regulatory
- Date in source: 2023-02-23
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-v1
- Content SHA-256: `a4828b9a8b7e2c98417496fd5a2cedde6afe76dd411dfb6647d659dabeceac3d`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 14 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history))

#### Summary

DailyMed lists Structured Product Labeling version 14 for the reviewed Pramlintide label family with a published date of 2023-02-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 14 for the reviewed Pramlintide label family with a published date of 2023-02-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 14 · published 2023-02-23 · retained ZIP SHA-256 7d6fd51c4f94786b1fea5204ff980c8906cdec9567d36f2d414187c85324040e** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=14) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 14." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v14-v1 SHA-256: a4828b9a8b7e2c98417496fd5a2cedde6afe76dd411dfb6647d659dabeceac3d.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-v1"></a>

## Pramlintide DailyMed SPL version 16

> DailyMed lists Structured Product Labeling version 16 for the reviewed Pramlintide label family with a published date of 2024-04-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16:v1`
- Evidence domain: Regulatory
- Date in source: 2024-04-15
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-v1
- Content SHA-256: `a036194ecdcb138a223aa9492470e626e028088863fe7b20eeee5c021715b948`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 16 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history))

#### Summary

DailyMed lists Structured Product Labeling version 16 for the reviewed Pramlintide label family with a published date of 2024-04-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 16 for the reviewed Pramlintide label family with a published date of 2024-04-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 16 · published 2024-04-15 · retained ZIP SHA-256 fa9d9a60eebb1d167ad7afc462c5a0a27d84216d21292f267c61c15f95c4b588** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=16) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 16." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v16-v1 SHA-256: a036194ecdcb138a223aa9492470e626e028088863fe7b20eeee5c021715b948.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-v1"></a>

## Pramlintide DailyMed SPL version 17

> DailyMed lists Structured Product Labeling version 17 for the reviewed Pramlintide label family with a published date of 2024-07-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17:v1`
- Evidence domain: Regulatory
- Date in source: 2024-07-09
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-v1
- Content SHA-256: `602313dbd391f15d3dab28bd82a4aa8a5b6c09cef0817caa40eb99c790f928b0`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 17 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history))

#### Summary

DailyMed lists Structured Product Labeling version 17 for the reviewed Pramlintide label family with a published date of 2024-07-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 17 for the reviewed Pramlintide label family with a published date of 2024-07-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 17 · published 2024-07-09 · retained ZIP SHA-256 10eeb5c9c379e8910c486794588ffa20041c70e53f89732bd7f1b87c3b6bbabe** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=17) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 17." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v17-v1 SHA-256: 602313dbd391f15d3dab28bd82a4aa8a5b6c09cef0817caa40eb99c790f928b0.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-v1"></a>

## Pramlintide DailyMed SPL version 18

> DailyMed lists Structured Product Labeling version 18 for the reviewed Pramlintide label family with a published date of 2024-08-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18:v1`
- Evidence domain: Regulatory
- Date in source: 2024-08-20
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-v1
- Content SHA-256: `eb438c5250bd25582366d6a53aae523dbf0e08994854a9f8ea0de6fd3c503e2f`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 18 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history))

#### Summary

DailyMed lists Structured Product Labeling version 18 for the reviewed Pramlintide label family with a published date of 2024-08-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 18 for the reviewed Pramlintide label family with a published date of 2024-08-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 18 · published 2024-08-20 · retained ZIP SHA-256 41e40e12d2e7bbf400a8bcd1a8032e423aa305f795982acb1264301692a93a15** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=18) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 18." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18-v1 SHA-256: eb438c5250bd25582366d6a53aae523dbf0e08994854a9f8ea0de6fd3c503e2f.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-v1"></a>

## Pramlintide DailyMed SPL version 1

> DailyMed lists Structured Product Labeling version 1 for the reviewed Pramlintide label family with a published date of 2015-01-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1:v1`
- Evidence domain: Regulatory
- Date in source: 2015-01-08
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-v1
- Content SHA-256: `749cd7e7fb7391f7cb4e017490241cf9bf8d6f7eeafd24b8cbebff9adf801432`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 1 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history))

#### Summary

DailyMed lists Structured Product Labeling version 1 for the reviewed Pramlintide label family with a published date of 2015-01-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 1 for the reviewed Pramlintide label family with a published date of 2015-01-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 1 · published 2015-01-08 · retained ZIP SHA-256 0de89f2b8b5aacc544a966f22b001ed6df459e3ecec86c4c8d88a6e5ad9104b4** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=1) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 1." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v1-v1 SHA-256: 749cd7e7fb7391f7cb4e017490241cf9bf8d6f7eeafd24b8cbebff9adf801432.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-v1"></a>

## Pramlintide DailyMed SPL version 2

> DailyMed lists Structured Product Labeling version 2 for the reviewed Pramlintide label family with a published date of 2015-03-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2:v1`
- Evidence domain: Regulatory
- Date in source: 2015-03-04
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-v1
- Content SHA-256: `44b65c6bb02e996ea2139ea7fe196edc066f4f15bfe423f5b961660143b60b38`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 2 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history))

#### Summary

DailyMed lists Structured Product Labeling version 2 for the reviewed Pramlintide label family with a published date of 2015-03-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 2 for the reviewed Pramlintide label family with a published date of 2015-03-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 2 · published 2015-03-04 · retained ZIP SHA-256 1c98bcb84b329e587cf49d21bf8b62704a59f793ec483960a7965be55d89dd4b** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=2) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 2." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v2-v1 SHA-256: 44b65c6bb02e996ea2139ea7fe196edc066f4f15bfe423f5b961660143b60b38.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-v1"></a>

## Pramlintide DailyMed SPL version 3

> DailyMed lists Structured Product Labeling version 3 for the reviewed Pramlintide label family with a published date of 2015-03-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3:v1`
- Evidence domain: Regulatory
- Date in source: 2015-03-30
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-v1
- Content SHA-256: `45aad73afa03bea6613ded49d154e88eac201d549887fc61a2930de246e67dd3`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 3 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history))

#### Summary

DailyMed lists Structured Product Labeling version 3 for the reviewed Pramlintide label family with a published date of 2015-03-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 3 for the reviewed Pramlintide label family with a published date of 2015-03-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 3 · published 2015-03-30 · retained ZIP SHA-256 97a88b2bbcc5cb444326a00ba231014ae8d2dbc626d62d083c882daacfc83985** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=3) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 3." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v3-v1 SHA-256: 45aad73afa03bea6613ded49d154e88eac201d549887fc61a2930de246e67dd3.

---

<a id="dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-v1"></a>

## Pramlintide DailyMed SPL version 4

> DailyMed lists Structured Product Labeling version 4 for the reviewed Pramlintide label family with a published date of 2016-04-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4:v1`
- Evidence domain: Regulatory
- Date in source: 2016-04-25
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-v1
- Content SHA-256: `3ba6e80773b04d680d3f65676750563db772d94fade0550ccfe95496b4e684e7`

### Claims and source pins

#### Headline

Pramlintide DailyMed SPL version 4 ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history))

#### Summary

DailyMed lists Structured Product Labeling version 4 for the reviewed Pramlintide label family with a published date of 2016-04-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 4 for the reviewed Pramlintide label family with a published date of 2016-04-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history`](#source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history))

### Sources

<a id="source-dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history"></a>
- **DailyMed SPL SET ID 4aea30ff-eb0d-45c1-b114-3127966328ff · SPL version 4 · published 2016-04-25 · retained ZIP SHA-256 596225f9ac1e659f9ca7f275e986ac24a0dcfaab7afa5a26029615747687d786** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=4) (`dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide DailyMed SPL version 4." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#dailymed-label-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v4-v1 SHA-256: 3ba6e80773b04d680d3f65676750563db772d94fade0550ccfe95496b4e684e7.

---

<a id="fda-drugs-nda021332-v1"></a>

## Drugs@FDA application NDA021332

> The official Drugs@FDA dataset lists original submission 1 for NDA 021332 with status AP dated 2005-03-16, and names pramlintide acetate among the application record's active ingredients.

- Evidence object: `story:fda-drugs-nda021332:v1`
- Evidence domain: Regulatory
- Date in source: 2005-03-16
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-nda021332/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#fda-drugs-nda021332-v1
- Content SHA-256: `a870b42536fae95f1898266c27c4ebb43b3e4380ff340fffe51c93f3cc784a08`

### Claims and source pins

#### Headline

Drugs@FDA application NDA021332 ([`fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e`](#source-fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for NDA 021332 with status AP dated 2005-03-16, and names pramlintide acetate among the application record's active ingredients. ([`fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e`](#source-fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for NDA 021332 with status AP dated 2005-03-16, and names pramlintide acetate among the application record's active ingredients. ([`fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e`](#source-fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e`](#source-fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e))

### Sources

<a id="source-fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e"></a>
- **Drugs@FDA application NDA021332 · original submission status AP · 2005-03-16 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA021332%22&limit=1) (`fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application NDA021332." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#fda-drugs-nda021332-v1 SHA-256: a870b42536fae95f1898266c27c4ebb43b3e4380ff340fffe51c93f3cc784a08.

---

<a id="federal-register-01-14410-v1"></a>

## Federal Register notice 01-14410

> The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide.

- Evidence object: `story:federal-register-01-14410:v1`
- Evidence domain: Regulatory
- Date in source: 2001-06-08
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-01-14410/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#federal-register-01-14410-v1
- Content SHA-256: `06c273cb8e838bf5f0b29682917ddd75c6bd9518c0e40a6f276969e68635d589`

### Claims and source pins

#### Headline

Federal Register notice 01-14410 ([`federal-register-01-14410-f2f6b677394b`](#source-federal-register-01-14410-f2f6b677394b))

#### Summary

The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide. ([`federal-register-01-14410-f2f6b677394b`](#source-federal-register-01-14410-f2f6b677394b))

#### Paragraph 1

The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide. ([`federal-register-01-14410-f2f6b677394b`](#source-federal-register-01-14410-f2f6b677394b))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-01-14410-f2f6b677394b`](#source-federal-register-01-14410-f2f6b677394b))

### Sources

<a id="source-federal-register-01-14410-f2f6b677394b"></a>
- **Federal Register notice 01-14410 · published 2001-06-08 · Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2001-06-08/pdf/01-14410.pdf) (`federal-register-01-14410-f2f6b677394b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 01-14410." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#federal-register-01-14410-v1 SHA-256: 06c273cb8e838bf5f0b29682917ddd75c6bd9518c0e40a6f276969e68635d589.

---

<a id="federal-register-e6-9414-v1"></a>

## Federal Register notice E6-9414

> The Federal Register published notice E6-9414, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SYMLIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide.

- Evidence object: `story:federal-register-e6-9414:v1`
- Evidence domain: Regulatory
- Date in source: 2006-06-16
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-e6-9414/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#federal-register-e6-9414-v1
- Content SHA-256: `84d5c8a567929e0617268bb52e936be2ca65de0961cf233aa2156688d7066259`

### Claims and source pins

#### Headline

Federal Register notice E6-9414 ([`federal-register-e6-9414-2541f31cb197`](#source-federal-register-e6-9414-2541f31cb197))

#### Summary

The Federal Register published notice E6-9414, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SYMLIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide. ([`federal-register-e6-9414-2541f31cb197`](#source-federal-register-e6-9414-2541f31cb197))

#### Paragraph 1

The Federal Register published notice E6-9414, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SYMLIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide. ([`federal-register-e6-9414-2541f31cb197`](#source-federal-register-e6-9414-2541f31cb197))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-e6-9414-2541f31cb197`](#source-federal-register-e6-9414-2541f31cb197))

### Sources

<a id="source-federal-register-e6-9414-2541f31cb197"></a>
- **Federal Register notice E6-9414 · published 2006-06-16 · Determination of Regulatory Review Period for Purposes of Patent Extension; SYMLIN** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2006-06-16/pdf/E6-9414.pdf) (`federal-register-e6-9414-2541f31cb197`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice E6-9414." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#federal-register-e6-9414-v1 SHA-256: 84d5c8a567929e0617268bb52e936be2ca65de0961cf233aa2156688d7066259.

---

<a id="pubmed-pmid-10576958-pramlintide-v1"></a>

## PubMed record PMID 10576958

> PeptideScanner retained PubMed bibliographic metadata for PMID 10576958 at 2026-07-30T21:56:55.038Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1999-11-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-10576958-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10576958-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-10576958-pramlintide-v1
- Content SHA-256: `5dbba425a9b3fd13e1d80c33e7292517a15bc0edfd67848121ba78349d755a0c`

### Claims and source pins

#### Headline

PubMed record PMID 10576958 ([`pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e`](#source-pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 10576958 at 2026-07-30T21:56:55.038Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1999-11-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e`](#source-pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 10576958 at 2026-07-30T21:56:55.038Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1999-11-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e`](#source-pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e`](#source-pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e))

### Sources

<a id="source-pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e"></a>
- **PubMed record PMID 10576958 · retained source version 1:2013-11-25:current:1452aed5ee4ef16c3eb6908c8a0c6c525fe654bb54a8e374bb714f5eb05a92a2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10576958/) (`pubmed-observation-pmid-10576958-2013-11-25-1452aed5ee4e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 10576958." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-10576958-pramlintide-v1 SHA-256: 5dbba425a9b3fd13e1d80c33e7292517a15bc0edfd67848121ba78349d755a0c.

---

<a id="pubmed-pmid-10701984-pramlintide-v1"></a>

## Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product.

> PubMed lists PMID 10701984 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-10701984-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-08-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10701984-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-10701984-pramlintide-v1
- Content SHA-256: `d044fac6cbca7600d1a4be55346a50029b55faeef128eaacdabb18063472d679`

### Claims and source pins

#### Headline

Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product. ([`pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64`](#source-pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64))

#### Summary

PubMed lists PMID 10701984 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64`](#source-pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64))

#### Paragraph 1

PubMed lists PMID 10701984 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64`](#source-pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64`](#source-pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64))

### Sources

<a id="source-pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64"></a>
- **Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product. · retained source version 1:2019-08-15:current:186cf3b01d6470977f3296bc7d7c0d10cc7cdbb448f04c7e65e0953335067b59** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10701984/) (`pubmed-observation-pmid-10701984-2019-08-15-186cf3b01d64`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-10701984-pramlintide-v1 SHA-256: d044fac6cbca7600d1a4be55346a50029b55faeef128eaacdabb18063472d679.

---

<a id="pubmed-pmid-10820656-pramlintide-v1"></a>

## Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin.

> PubMed lists PMID 10820656 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-10820656-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-10-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10820656-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-10820656-pramlintide-v1
- Content SHA-256: `3a5e848a8129ec5db7b9f60c4031e9f18b7b83087ba325185c53101eb0932e88`

### Claims and source pins

#### Headline

Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

#### Summary

PubMed lists PMID 10820656 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

#### Paragraph 1

PubMed lists PMID 10820656 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

### Sources

<a id="source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e"></a>
- **Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin. · retained source version 1:2018-10-25:current:f5b06799125e81a9737603debfd9fceb63c724b6613e9c70f8d5bc8ab9e9911e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10820656/) (`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-10820656-pramlintide-v1 SHA-256: 3a5e848a8129ec5db7b9f60c4031e9f18b7b83087ba325185c53101eb0932e88.

---

<a id="pubmed-pmid-11710342-pramlintide-v1"></a>

## PubMed record PMID 11710342

> PeptideScanner retained PubMed bibliographic metadata for PMID 11710342 at 2026-07-30T21:56:55.058Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2001-11-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-11710342-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-11710342-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-11710342-pramlintide-v1
- Content SHA-256: `25ca8d7997747865b201854f2b3c20f3c194a59dbf9712995acca5cfb8e1047d`

### Claims and source pins

#### Headline

PubMed record PMID 11710342 ([`pubmed-observation-pmid-11710342-2013-11-25-0bc149053645`](#source-pubmed-observation-pmid-11710342-2013-11-25-0bc149053645))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 11710342 at 2026-07-30T21:56:55.058Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2001-11-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11710342-2013-11-25-0bc149053645`](#source-pubmed-observation-pmid-11710342-2013-11-25-0bc149053645))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 11710342 at 2026-07-30T21:56:55.058Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2001-11-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11710342-2013-11-25-0bc149053645`](#source-pubmed-observation-pmid-11710342-2013-11-25-0bc149053645))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-11710342-2013-11-25-0bc149053645`](#source-pubmed-observation-pmid-11710342-2013-11-25-0bc149053645))

### Sources

<a id="source-pubmed-observation-pmid-11710342-2013-11-25-0bc149053645"></a>
- **PubMed record PMID 11710342 · retained source version 1:2013-11-25:current:0bc149053645b30ed8badf50c6b245397e484fcd8f8ada88851da02227027116** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/11710342/) (`pubmed-observation-pmid-11710342-2013-11-25-0bc149053645`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 11710342." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-11710342-pramlintide-v1 SHA-256: 25ca8d7997747865b201854f2b3c20f3c194a59dbf9712995acca5cfb8e1047d.

---

<a id="pubmed-pmid-11763160-pramlintide-v1"></a>

## PubMed record PMID 11763160

> PeptideScanner retained PubMed bibliographic metadata for PMID 11763160 at 2026-07-30T21:56:55.060Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-01-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-11763160-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-11763160-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-11763160-pramlintide-v1
- Content SHA-256: `193d66ed4bfb3fec8156d6b0534517c8dcea0cc1ca7d115275bc8ee2492e3422`

### Claims and source pins

#### Headline

PubMed record PMID 11763160 ([`pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea`](#source-pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 11763160 at 2026-07-30T21:56:55.060Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-01-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea`](#source-pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 11763160 at 2026-07-30T21:56:55.060Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-01-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea`](#source-pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea`](#source-pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea))

### Sources

<a id="source-pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea"></a>
- **PubMed record PMID 11763160 · retained source version 1:2013-11-25:current:0239b942b1ea06e11b8a9577519c7576aa7c2611361e74d0afd63c51f85b8d48** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/11763160/) (`pubmed-observation-pmid-11763160-2013-11-25-0239b942b1ea`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 11763160." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-11763160-pramlintide-v1 SHA-256: 193d66ed4bfb3fec8156d6b0534517c8dcea0cc1ca7d115275bc8ee2492e3422.

---

<a id="pubmed-pmid-12017422-pramlintide-v1"></a>

## PubMed record PMID 12017422

> PeptideScanner retained PubMed bibliographic metadata for PMID 12017422 at 2026-07-30T21:56:55.064Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-05-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-12017422-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-12017422-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12017422-pramlintide-v1
- Content SHA-256: `998775b86baae9ad7fef93205edf64e2f36150e9b9a09bfdf4ed1ae40cd7391c`

### Claims and source pins

#### Headline

PubMed record PMID 12017422 ([`pubmed-observation-pmid-12017422-2013-11-25-034d693383f4`](#source-pubmed-observation-pmid-12017422-2013-11-25-034d693383f4))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 12017422 at 2026-07-30T21:56:55.064Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-05-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12017422-2013-11-25-034d693383f4`](#source-pubmed-observation-pmid-12017422-2013-11-25-034d693383f4))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 12017422 at 2026-07-30T21:56:55.064Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-05-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12017422-2013-11-25-034d693383f4`](#source-pubmed-observation-pmid-12017422-2013-11-25-034d693383f4))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-12017422-2013-11-25-034d693383f4`](#source-pubmed-observation-pmid-12017422-2013-11-25-034d693383f4))

### Sources

<a id="source-pubmed-observation-pmid-12017422-2013-11-25-034d693383f4"></a>
- **PubMed record PMID 12017422 · retained source version 1:2013-11-25:current:034d693383f43e30e3b354d4a16133468806a569b6b6dcd5965e260c0af0bc82** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/12017422/) (`pubmed-observation-pmid-12017422-2013-11-25-034d693383f4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 12017422." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12017422-pramlintide-v1 SHA-256: 998775b86baae9ad7fef93205edf64e2f36150e9b9a09bfdf4ed1ae40cd7391c.

---

<a id="pubmed-pmid-12079622-pramlintide-v1"></a>

## PubMed record PMID 12079622

> PeptideScanner retained PubMed bibliographic metadata for PMID 12079622 at 2026-07-30T21:56:55.908Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-06-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-12079622-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-12079622-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12079622-pramlintide-v1
- Content SHA-256: `55c1b155e6294151d6190ccf3193312f5728e0ee1fff2d55387dce2f6ceb41a4`

### Claims and source pins

#### Headline

PubMed record PMID 12079622 ([`pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04`](#source-pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 12079622 at 2026-07-30T21:56:55.908Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-06-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04`](#source-pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 12079622 at 2026-07-30T21:56:55.908Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-06-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04`](#source-pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04`](#source-pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04))

### Sources

<a id="source-pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04"></a>
- **PubMed record PMID 12079622 · retained source version 1:2013-11-25:current:92e79dc62b04f762da797bd33ddc61eb67f050d6140123444d467fef87904267** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/12079622/) (`pubmed-observation-pmid-12079622-2013-11-25-92e79dc62b04`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 12079622." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12079622-pramlintide-v1 SHA-256: 55c1b155e6294151d6190ccf3193312f5728e0ee1fff2d55387dce2f6ceb41a4.

---

<a id="pubmed-pmid-12534323-pramlintide-v1"></a>

## Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin).

> PubMed lists PMID 12534323 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-12534323-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-10-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-12534323-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12534323-pramlintide-v1
- Content SHA-256: `e28f10b8599c58fb31739980f5c68ac6eb9bf8ccff99f87cd96dc8944409496c`

### Claims and source pins

#### Headline

Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin). ([`pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a`](#source-pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a))

#### Summary

PubMed lists PMID 12534323 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a`](#source-pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a))

#### Paragraph 1

PubMed lists PMID 12534323 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a`](#source-pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a`](#source-pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a))

### Sources

<a id="source-pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a"></a>
- **Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin). · retained source version 1:2018-10-25:current:3bbaf052810afe73b17d0c4d49e5da3f308319e834496da323416be38338a6d4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/12534323/) (`pubmed-observation-pmid-12534323-2018-10-25-3bbaf052810a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin)." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12534323-pramlintide-v1 SHA-256: e28f10b8599c58fb31739980f5c68ac6eb9bf8ccff99f87cd96dc8944409496c.

---

<a id="pubmed-pmid-12685439-pramlintide-v1"></a>

## Pramlintide as an adjunct to insulin therapy.

> PubMed lists PMID 12685439 in Current diabetes reports as Comment, Journal Article, with publication-date metadata of 2003-02 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-12685439-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-11-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-12685439-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12685439-pramlintide-v1
- Content SHA-256: `4b5e886a8f39dfbf4e7d3551419d5ba69577f8b91003956fe89ce33b8467a071`

### Claims and source pins

#### Headline

Pramlintide as an adjunct to insulin therapy. ([`pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285`](#source-pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285))

#### Summary

PubMed lists PMID 12685439 in Current diabetes reports as Comment, Journal Article, with publication-date metadata of 2003-02 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285`](#source-pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285))

#### Paragraph 1

PubMed lists PMID 12685439 in Current diabetes reports as Comment, Journal Article, with publication-date metadata of 2003-02 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285`](#source-pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285`](#source-pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285))

### Sources

<a id="source-pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285"></a>
- **Pramlintide as an adjunct to insulin therapy. · retained source version 1:2019-11-07:current:0ccb5ce04285642b3a517ba52c82c1d780d4029127a06cb7dc7e5f0e760806a6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/12685439/) (`pubmed-observation-pmid-12685439-2019-11-07-0ccb5ce04285`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide as an adjunct to insulin therapy." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-12685439-pramlintide-v1 SHA-256: 4b5e886a8f39dfbf4e7d3551419d5ba69577f8b91003956fe89ce33b8467a071.

---

<a id="pubmed-pmid-14727840-pramlintide-v1"></a>

## Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.

> PubMed lists PMID 14727840 in AAPS PharmSciTech as Comparative Study, Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-14727840-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-11-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-14727840-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14727840-pramlintide-v1
- Content SHA-256: `b9c955ca3f04426139a863986df89142a83cfaa25de72b8b5d3edc77b2334e72`

### Claims and source pins

#### Headline

Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH. ([`pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7`](#source-pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7))

#### Summary

PubMed lists PMID 14727840 in AAPS PharmSciTech as Comparative Study, Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7`](#source-pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7))

#### Paragraph 1

PubMed lists PMID 14727840 in AAPS PharmSciTech as Comparative Study, Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7`](#source-pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7`](#source-pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7))

### Sources

<a id="source-pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7"></a>
- **Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH. · retained source version 1:2018-11-13:current:3a23aa177fe7f5524214364c0a9f87cfa8b5924b3ecd8661eba908c667ee2dde** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/14727840/) (`pubmed-observation-pmid-14727840-2018-11-13-3a23aa177fe7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14727840-pramlintide-v1 SHA-256: b9c955ca3f04426139a863986df89142a83cfaa25de72b8b5d3edc77b2334e72.

---

<a id="pubmed-pmid-14727841-pramlintide-v1"></a>

## Pramlintide injection drug product robustness studies.

> PubMed lists PMID 14727841 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-14727841-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-11-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-14727841-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14727841-pramlintide-v1
- Content SHA-256: `4c51ad684cba6e1463fd42a7594a87cddd582b16afb695ca2e48a712c63a8c00`

### Claims and source pins

#### Headline

Pramlintide injection drug product robustness studies. ([`pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55`](#source-pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55))

#### Summary

PubMed lists PMID 14727841 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55`](#source-pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55))

#### Paragraph 1

PubMed lists PMID 14727841 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55`](#source-pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55`](#source-pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55))

### Sources

<a id="source-pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55"></a>
- **Pramlintide injection drug product robustness studies. · retained source version 1:2018-11-13:current:ac0f19f7cf55af2454d24889217557d76a72e9d7eabdbfe5fef1777c304891b7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/14727841/) (`pubmed-observation-pmid-14727841-2018-11-13-ac0f19f7cf55`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide injection drug product robustness studies." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14727841-pramlintide-v1 SHA-256: 4c51ad684cba6e1463fd42a7594a87cddd582b16afb695ca2e48a712c63a8c00.

---

<a id="pubmed-pmid-14727855-pramlintide-v1"></a>

## Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide.

> PubMed lists PMID 14727855 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-14727855-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-11-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-14727855-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14727855-pramlintide-v1
- Content SHA-256: `324256a29c98e5c237aecf6f0e54a17157802aa4769f9abbf48e4c15f71d61a6`

### Claims and source pins

#### Headline

Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide. ([`pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b`](#source-pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b))

#### Summary

PubMed lists PMID 14727855 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b`](#source-pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b))

#### Paragraph 1

PubMed lists PMID 14727855 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b`](#source-pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b`](#source-pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b))

### Sources

<a id="source-pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b"></a>
- **Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide. · retained source version 1:2018-11-13:current:1c0111758a0b67dfe91a43f13502988b6cfd7dbaa2391ad4c9ba868f2154346f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/14727855/) (`pubmed-observation-pmid-14727855-2018-11-13-1c0111758a0b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14727855-pramlintide-v1 SHA-256: 324256a29c98e5c237aecf6f0e54a17157802aa4769f9abbf48e4c15f71d61a6.

---

<a id="pubmed-pmid-14737746-pramlintide-v1"></a>

## PubMed record PMID 14737746

> PeptideScanner retained PubMed bibliographic metadata for PMID 14737746 at 2026-07-30T21:56:55.928Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2004-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-14737746-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-14737746-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14737746-pramlintide-v1
- Content SHA-256: `74fca34232dbfda2621d321013f00ea8461b25ceb5c1bbe472fdc6fdcc70d87c`

### Claims and source pins

#### Headline

PubMed record PMID 14737746 ([`pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c`](#source-pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 14737746 at 2026-07-30T21:56:55.928Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2004-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c`](#source-pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 14737746 at 2026-07-30T21:56:55.928Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2004-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c`](#source-pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c`](#source-pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c))

### Sources

<a id="source-pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c"></a>
- **PubMed record PMID 14737746 · retained source version 1:2013-11-25:current:f0cc63f78a2ca40abd325a89cedf8a2e9a6c51d69f3f4f4de97d64098f274c7d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/14737746/) (`pubmed-observation-pmid-14737746-2013-11-25-f0cc63f78a2c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 14737746." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-14737746-pramlintide-v1 SHA-256: 74fca34232dbfda2621d321013f00ea8461b25ceb5c1bbe472fdc6fdcc70d87c.

---

<a id="pubmed-pmid-15821274-pramlintide-v1"></a>

## Properties of pramlintide and insulin upon mixing.

> PubMed lists PMID 15821274 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2005-04-15 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15821274-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-02-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15821274-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-15821274-pramlintide-v1
- Content SHA-256: `3362460d05f299d23c6d6af83c0c954af00d64b5a64470afe97db31cd86e86fc`

### Claims and source pins

#### Headline

Properties of pramlintide and insulin upon mixing. ([`pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca`](#source-pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca))

#### Summary

PubMed lists PMID 15821274 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2005-04-15 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca`](#source-pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca))

#### Paragraph 1

PubMed lists PMID 15821274 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2005-04-15 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca`](#source-pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca`](#source-pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca))

### Sources

<a id="source-pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca"></a>
- **Properties of pramlintide and insulin upon mixing. · retained source version 1:2019-02-22:current:0795399ea0caba8b25e5b62e3abf166e5c678cd693f73bfbbddd0f082327780e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15821274/) (`pubmed-observation-pmid-15821274-2019-02-22-0795399ea0ca`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Properties of pramlintide and insulin upon mixing." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-15821274-pramlintide-v1 SHA-256: 3362460d05f299d23c6d6af83c0c954af00d64b5a64470afe97db31cd86e86fc.

---

<a id="pubmed-pmid-15912124-pramlintide-v1"></a>

## PubMed record PMID 15912124

> PeptideScanner retained PubMed bibliographic metadata for PMID 15912124 at 2026-07-30T21:56:56.704Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-05-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-15912124-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15912124-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-15912124-pramlintide-v1
- Content SHA-256: `f4ec7ace0f083266cad8229c7eb075d65afacbb28d01fa2743490a4e7b067fb1`

### Claims and source pins

#### Headline

PubMed record PMID 15912124 ([`pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9`](#source-pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 15912124 at 2026-07-30T21:56:56.704Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-05-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9`](#source-pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 15912124 at 2026-07-30T21:56:56.704Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-05-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9`](#source-pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9`](#source-pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9))

### Sources

<a id="source-pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9"></a>
- **PubMed record PMID 15912124 · retained source version 1:2013-11-25:current:f59dc7dc49d9d4149c70d4e5b708d74d6c9cc97b611717b6980218889f1f4801** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15912124/) (`pubmed-observation-pmid-15912124-2013-11-25-f59dc7dc49d9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 15912124." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-15912124-pramlintide-v1 SHA-256: f4ec7ace0f083266cad8229c7eb075d65afacbb28d01fa2743490a4e7b067fb1.

---

<a id="pubmed-pmid-16050943-pramlintide-v1"></a>

## PubMed record PMID 16050943

> PeptideScanner retained PubMed bibliographic metadata for PMID 16050943 at 2026-07-30T21:56:56.707Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-07-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-16050943-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-16050943-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-16050943-pramlintide-v1
- Content SHA-256: `6485121d254cd59e463f7cdddd5ecc148c7d2d36a3fc233d5aad7149a12ba32e`

### Claims and source pins

#### Headline

PubMed record PMID 16050943 ([`pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca`](#source-pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 16050943 at 2026-07-30T21:56:56.707Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-07-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca`](#source-pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 16050943 at 2026-07-30T21:56:56.707Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-07-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca`](#source-pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca`](#source-pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca))

### Sources

<a id="source-pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca"></a>
- **PubMed record PMID 16050943 · retained source version 1:2013-11-25:current:5a680c36b8ca4202809cb7b737f595255d9aa25498c4565521a25a7b40f06c4f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/16050943/) (`pubmed-observation-pmid-16050943-2013-11-25-5a680c36b8ca`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 16050943." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-16050943-pramlintide-v1 SHA-256: 6485121d254cd59e463f7cdddd5ecc148c7d2d36a3fc233d5aad7149a12ba32e.

---

<a id="pubmed-pmid-17064208-pramlintide-v1"></a>

## Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.

> PubMed lists PMID 17064208 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-11 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-17064208-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17064208-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17064208-pramlintide-v1
- Content SHA-256: `c7b1ed5f0c267164d1688fc85da56951f74d8c4456948ea5a9d1d99036e9cd86`

### Claims and source pins

#### Headline

Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

#### Summary

PubMed lists PMID 17064208 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-11 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

#### Paragraph 1

PubMed lists PMID 17064208 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-11 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

### Sources

<a id="source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8"></a>
- **Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. · retained source version 1:2026-01-28:current:fa251b343ad891312060e741d73844c29f7b0dc686f7f3b1e840747757874074** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17064208/) (`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17064208-pramlintide-v1 SHA-256: c7b1ed5f0c267164d1688fc85da56951f74d8c4456948ea5a9d1d99036e9cd86.

---

<a id="pubmed-pmid-17624233-pramlintide-v1"></a>

## Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy.

> PubMed lists PMID 17624233 in Current medical research and opinion as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-17624233-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17624233-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17624233-pramlintide-v1
- Content SHA-256: `c1ba50b351646451d72f5207b00faaea9f92b308bf6fbb3ac11ff2e4842fee89`

### Claims and source pins

#### Headline

Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy. ([`pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3`](#source-pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3))

#### Summary

PubMed lists PMID 17624233 in Current medical research and opinion as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3`](#source-pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3))

#### Paragraph 1

PubMed lists PMID 17624233 in Current medical research and opinion as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3`](#source-pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3`](#source-pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3))

### Sources

<a id="source-pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3"></a>
- **Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy. · retained source version 1:2026-01-28:current:189f530b1df3d6c06b25f2d313ede762997a3fb8e7e743845fed7f22720ce172** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17624233/) (`pubmed-observation-pmid-17624233-2026-01-28-189f530b1df3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17624233-pramlintide-v1 SHA-256: c1ba50b351646451d72f5207b00faaea9f92b308bf6fbb3ac11ff2e4842fee89.

---

<a id="pubmed-pmid-17879973-pramlintide-v1"></a>

## PubMed record PMID 17879973

> PeptideScanner retained PubMed bibliographic metadata for PMID 17879973 at 2026-07-30T21:56:58.631Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2007-09-21. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-17879973-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17879973-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17879973-pramlintide-v1
- Content SHA-256: `b43e2c2195757074bd09b57603ba1c6bc2c5d3261627610bcb903dfc65ca2c09`

### Claims and source pins

#### Headline

PubMed record PMID 17879973 ([`pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88`](#source-pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 17879973 at 2026-07-30T21:56:58.631Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2007-09-21. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88`](#source-pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 17879973 at 2026-07-30T21:56:58.631Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2007-09-21. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88`](#source-pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88`](#source-pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88))

### Sources

<a id="source-pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88"></a>
- **PubMed record PMID 17879973 · retained source version 1:2013-11-25:current:020c1683fd88782e25346f4adef25cff43df71ff86d00b1c0b49868f044ba496** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17879973/) (`pubmed-observation-pmid-17879973-2013-11-25-020c1683fd88`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 17879973." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17879973-pramlintide-v1 SHA-256: b43e2c2195757074bd09b57603ba1c6bc2c5d3261627610bcb903dfc65ca2c09.

---

<a id="pubmed-pmid-17909093-pramlintide-v1"></a>

## Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes.

> PubMed lists PMID 17909093 in Diabetes care as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-01 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-17909093-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17909093-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17909093-pramlintide-v1
- Content SHA-256: `a7180022bb8a7a9c0bb83694bdb3af143254bec764aa571bc6cbef5b4c065c50`

### Claims and source pins

#### Headline

Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

#### Summary

PubMed lists PMID 17909093 in Diabetes care as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-01 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

#### Paragraph 1

PubMed lists PMID 17909093 in Diabetes care as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-01 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

### Sources

<a id="source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba"></a>
- **Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes. · retained source version 1:2026-01-28:current:a87fc8d4c0baa9b4f8f784f8200f53c3f7c4fc347addd2fcd5580620d09afaed** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17909093/) (`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-17909093-pramlintide-v1 SHA-256: a7180022bb8a7a9c0bb83694bdb3af143254bec764aa571bc6cbef5b4c065c50.

---

<a id="pubmed-pmid-18283327-pramlintide-v1"></a>

## PubMed record PMID 18283327

> PeptideScanner retained PubMed bibliographic metadata for PMID 18283327 at 2026-07-30T22:38:13.895Z. PubMed recorded a metadata revision date of 2008-03-21 and an Entrez history date of 2008-02-20. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-18283327-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2008-03-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-18283327-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-18283327-pramlintide-v1
- Content SHA-256: `bbb55835787149fef1c791128bbb2d79186442ad0b3589f644e6d78e191c5fca`

### Claims and source pins

#### Headline

PubMed record PMID 18283327 ([`pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d`](#source-pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 18283327 at 2026-07-30T22:38:13.895Z. PubMed recorded a metadata revision date of 2008-03-21 and an Entrez history date of 2008-02-20. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d`](#source-pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 18283327 at 2026-07-30T22:38:13.895Z. PubMed recorded a metadata revision date of 2008-03-21 and an Entrez history date of 2008-02-20. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d`](#source-pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d`](#source-pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d))

### Sources

<a id="source-pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d"></a>
- **PubMed record PMID 18283327 · retained source version 1:2008-03-21:current:ae6bc3d3b21d19db80c4664f7b98e92b701a46fdc335ac9badc06aac351e4a9a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/18283327/) (`pubmed-observation-pmid-18283327-2008-03-21-ae6bc3d3b21d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 18283327." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-18283327-pramlintide-v1 SHA-256: bbb55835787149fef1c791128bbb2d79186442ad0b3589f644e6d78e191c5fca.

---

<a id="pubmed-pmid-19502544-pramlintide-v1"></a>

## Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes.

> PubMed lists PMID 19502544 in Diabetes care as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-06-05 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-19502544-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-08-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19502544-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19502544-pramlintide-v1
- Content SHA-256: `24ddc44bba1362059dab49b9ae924da3bdcf418c997e40a5aea7f80188c72ac0`

### Claims and source pins

#### Headline

Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes. ([`pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde`](#source-pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde))

#### Summary

PubMed lists PMID 19502544 in Diabetes care as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-06-05 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde`](#source-pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde))

#### Paragraph 1

PubMed lists PMID 19502544 in Diabetes care as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-06-05 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde`](#source-pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde`](#source-pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde))

### Sources

<a id="source-pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde"></a>
- **Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes. · retained source version 1:2025-08-13:current:ec4057673cded7f347da2ac2d1e5cdf7f0cabec9e02eff227a89b03cae22538a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19502544/) (`pubmed-observation-pmid-19502544-2025-08-13-ec4057673cde`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19502544-pramlintide-v1 SHA-256: 24ddc44bba1362059dab49b9ae924da3bdcf418c997e40a5aea7f80188c72ac0.

---

<a id="pubmed-pmid-19546056-pramlintide-v1"></a>

## Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study.

> PubMed lists PMID 19546056 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-19546056-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19546056-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19546056-pramlintide-v1
- Content SHA-256: `d2900968266ecaf1fa84de909574af1c380aa44c2c16fdab01a3d63243e88dea`

### Claims and source pins

#### Headline

Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study. ([`pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88`](#source-pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88))

#### Summary

PubMed lists PMID 19546056 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88`](#source-pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88))

#### Paragraph 1

PubMed lists PMID 19546056 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88`](#source-pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88`](#source-pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88))

### Sources

<a id="source-pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88"></a>
- **Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study. · retained source version 1:2026-01-28:current:f23ada615c8852418e57fcd9370a05c6c42481ce21261cf8cbd95b4443e36e4c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19546056/) (`pubmed-observation-pmid-19546056-2026-01-28-f23ada615c88`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19546056-pramlintide-v1 SHA-256: d2900968266ecaf1fa84de909574af1c380aa44c2c16fdab01a3d63243e88dea.

---

<a id="pubmed-pmid-19732574-pramlintide-v1"></a>

## PubMed record PMID 19732574

> PeptideScanner retained PubMed bibliographic metadata for PMID 19732574 at 2026-07-30T21:56:59.483Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2009-09-08. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-19732574-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19732574-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19732574-pramlintide-v1
- Content SHA-256: `5cbf3acc52078d0ec795de148f43cc0e97de6b6be2dc0532b4564b727519cc7f`

### Claims and source pins

#### Headline

PubMed record PMID 19732574 ([`pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf`](#source-pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 19732574 at 2026-07-30T21:56:59.483Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2009-09-08. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf`](#source-pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 19732574 at 2026-07-30T21:56:59.483Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2009-09-08. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf`](#source-pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf`](#source-pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf))

### Sources

<a id="source-pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf"></a>
- **PubMed record PMID 19732574 · retained source version 1:2013-11-25:current:d785f6a24bcf928d08ddd9454724c56590be1e7d503f6c4204224049ec658ce3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19732574/) (`pubmed-observation-pmid-19732574-2013-11-25-d785f6a24bcf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 19732574." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19732574-pramlintide-v1 SHA-256: 5cbf3acc52078d0ec795de148f43cc0e97de6b6be2dc0532b4564b727519cc7f.

---

<a id="pubmed-pmid-19858155-pramlintide-v1"></a>

## A pilot trial of pramlintide home usage in adolescents with type 1 diabetes.

> PubMed lists PMID 19858155 in Pediatrics as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2009-10-26 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-19858155-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19858155-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19858155-pramlintide-v1
- Content SHA-256: `e41b3b0dd4219b0faf2ba3bbd39775dd792f782afd7ed7af395e6c465b43cac2`

### Claims and source pins

#### Headline

A pilot trial of pramlintide home usage in adolescents with type 1 diabetes. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

#### Summary

PubMed lists PMID 19858155 in Pediatrics as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2009-10-26 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

#### Paragraph 1

PubMed lists PMID 19858155 in Pediatrics as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2009-10-26 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

### Sources

<a id="source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed"></a>
- **A pilot trial of pramlintide home usage in adolescents with type 1 diabetes. · retained source version 1:2026-01-28:current:6983cb4bd2ed2fe7663e758e7c42a6aa519c03211b95cf6b0dd5789198a7ca3d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19858155/) (`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "A pilot trial of pramlintide home usage in adolescents with type 1 diabetes." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-19858155-pramlintide-v1 SHA-256: e41b3b0dd4219b0faf2ba3bbd39775dd792f782afd7ed7af395e6c465b43cac2.

---

<a id="pubmed-pmid-20094043-pramlintide-v1"></a>

## PubMed record PMID 20094043

> PeptideScanner retained PubMed bibliographic metadata for PMID 20094043 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-20094043-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20094043-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-20094043-pramlintide-v1
- Content SHA-256: `6bfa2cd906ebea5e6e8fe36804a2014f574027b1df14df1c2e2a0d9caa3cb82e`

### Claims and source pins

#### Headline

PubMed record PMID 20094043 ([`pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3`](#source-pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 20094043 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3`](#source-pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 20094043 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3`](#source-pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3`](#source-pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3))

### Sources

<a id="source-pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3"></a>
- **PubMed record PMID 20094043 · retained source version 1:2013-11-25:current:0014ede9f4f38993b78a7a93020ab095c1c08cd174c96ab710e424a6d011796e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20094043/) (`pubmed-observation-pmid-20094043-2013-11-25-0014ede9f4f3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 20094043." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-20094043-pramlintide-v1 SHA-256: 6bfa2cd906ebea5e6e8fe36804a2014f574027b1df14df1c2e2a0d9caa3cb82e.

---

<a id="pubmed-pmid-20105039-pramlintide-v1"></a>

## PubMed record PMID 20105039

> PeptideScanner retained PubMed bibliographic metadata for PMID 20105039 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-20105039-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20105039-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-20105039-pramlintide-v1
- Content SHA-256: `e569842641580454ea06f504295c86a5c9870491c08d69c26989c66dd602ef4e`

### Claims and source pins

#### Headline

PubMed record PMID 20105039 ([`pubmed-observation-pmid-20105039-2013-11-25-1276daf94383`](#source-pubmed-observation-pmid-20105039-2013-11-25-1276daf94383))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 20105039 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20105039-2013-11-25-1276daf94383`](#source-pubmed-observation-pmid-20105039-2013-11-25-1276daf94383))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 20105039 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20105039-2013-11-25-1276daf94383`](#source-pubmed-observation-pmid-20105039-2013-11-25-1276daf94383))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20105039-2013-11-25-1276daf94383`](#source-pubmed-observation-pmid-20105039-2013-11-25-1276daf94383))

### Sources

<a id="source-pubmed-observation-pmid-20105039-2013-11-25-1276daf94383"></a>
- **PubMed record PMID 20105039 · retained source version 1:2013-11-25:current:1276daf94383381b1109536555a5dd0e1f9509697eb1903589c88dbbd5784c49** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20105039/) (`pubmed-observation-pmid-20105039-2013-11-25-1276daf94383`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 20105039." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-20105039-pramlintide-v1 SHA-256: e569842641580454ea06f504295c86a5c9870491c08d69c26989c66dd602ef4e.

---

<a id="pubmed-pmid-20164472-pramlintide-v1"></a>

## PubMed record PMID 20164472

> PeptideScanner retained PubMed bibliographic metadata for PMID 20164472 at 2026-07-30T21:56:59.488Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-02-19. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-20164472-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20164472-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-20164472-pramlintide-v1
- Content SHA-256: `c40a31f2b56f607a04a56049e7f27f5262060014fd6cd80a88739de47ca7de20`

### Claims and source pins

#### Headline

PubMed record PMID 20164472 ([`pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1`](#source-pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 20164472 at 2026-07-30T21:56:59.488Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-02-19. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1`](#source-pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 20164472 at 2026-07-30T21:56:59.488Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-02-19. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1`](#source-pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1`](#source-pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1))

### Sources

<a id="source-pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1"></a>
- **PubMed record PMID 20164472 · retained source version 1:2013-11-25:current:0163a25779d13fc172d135c7209813df01246ab3ae9c417e1ca7ae795d668446** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20164472/) (`pubmed-observation-pmid-20164472-2013-11-25-0163a25779d1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 20164472." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-20164472-pramlintide-v1 SHA-256: c40a31f2b56f607a04a56049e7f27f5262060014fd6cd80a88739de47ca7de20.

---

<a id="pubmed-pmid-21564002-pramlintide-v1"></a>

## Pramlintide and the treatment of diabetes: a review of the data since its introduction.

> PubMed lists PMID 21564002 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2011-05-13 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-21564002-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-03-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-21564002-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-21564002-pramlintide-v1
- Content SHA-256: `0dfc8482bfac1ac7d1218cb282f154017049c18d75fbb8aad476a42324485324`

### Claims and source pins

#### Headline

Pramlintide and the treatment of diabetes: a review of the data since its introduction. ([`pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177`](#source-pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177))

#### Summary

PubMed lists PMID 21564002 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2011-05-13 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177`](#source-pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177))

#### Paragraph 1

PubMed lists PMID 21564002 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2011-05-13 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177`](#source-pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177`](#source-pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177))

### Sources

<a id="source-pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177"></a>
- **Pramlintide and the treatment of diabetes: a review of the data since its introduction. · retained source version 1:2022-03-21:current:ea360fab1177735145ca06a3b6935bf791ae9885ad83fee10ff0b0ab1b6556a2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/21564002/) (`pubmed-observation-pmid-21564002-2022-03-21-ea360fab1177`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pramlintide and the treatment of diabetes: a review of the data since its introduction." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-21564002-pramlintide-v1 SHA-256: 0dfc8482bfac1ac7d1218cb282f154017049c18d75fbb8aad476a42324485324.

---

<a id="pubmed-pmid-23452312-pramlintide-v1"></a>

## PubMed record PMID 23452312

> PeptideScanner retained PubMed bibliographic metadata for PMID 23452312 at 2026-07-30T21:57:01.406Z. PubMed recorded a metadata revision date of 2013-04-29 and an Entrez history date of 2013-03-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-23452312-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-04-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23452312-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-23452312-pramlintide-v1
- Content SHA-256: `cbd744245c9ee37b16415af1d88b139bee04256e209314e98d3fa15a482042b4`

### Claims and source pins

#### Headline

PubMed record PMID 23452312 ([`pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df`](#source-pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 23452312 at 2026-07-30T21:57:01.406Z. PubMed recorded a metadata revision date of 2013-04-29 and an Entrez history date of 2013-03-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df`](#source-pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 23452312 at 2026-07-30T21:57:01.406Z. PubMed recorded a metadata revision date of 2013-04-29 and an Entrez history date of 2013-03-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df`](#source-pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df`](#source-pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df))

### Sources

<a id="source-pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df"></a>
- **PubMed record PMID 23452312 · retained source version 1:2013-04-29:current:b8f0682561df9fc56e7658b20e51d2e56bc75d9673a09f8966e8d97c1ecec7a9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23452312/) (`pubmed-observation-pmid-23452312-2013-04-29-b8f0682561df`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 23452312." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-23452312-pramlintide-v1 SHA-256: cbd744245c9ee37b16415af1d88b139bee04256e209314e98d3fa15a482042b4.

---

<a id="pubmed-pmid-23865841-pramlintide-v1"></a>

## In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.

> PubMed lists PMID 23865841 in Diabetes technology & therapeutics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23865841-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-10-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23865841-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-23865841-pramlintide-v1
- Content SHA-256: `a9d3ea2d162855b9d97c2e209c59960bd45a83ccae9729ba5ad8182a9b4f3e33`

### Claims and source pins

#### Headline

In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes. ([`pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9`](#source-pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9))

#### Summary

PubMed lists PMID 23865841 in Diabetes technology & therapeutics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9`](#source-pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9))

#### Paragraph 1

PubMed lists PMID 23865841 in Diabetes technology & therapeutics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9`](#source-pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9`](#source-pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9))

### Sources

<a id="source-pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9"></a>
- **In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes. · retained source version 1:2021-10-21:current:4b129d2498b98594f36f6d94b9a2f7c0a48007c6832292a3cdeab66d79098870** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23865841/) (`pubmed-observation-pmid-23865841-2021-10-21-4b129d2498b9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-23865841-pramlintide-v1 SHA-256: a9d3ea2d162855b9d97c2e209c59960bd45a83ccae9729ba5ad8182a9b4f3e33.

---

<a id="pubmed-pmid-24123422-pramlintide-v1"></a>

## PubMed record PMID 24123422

> PeptideScanner retained PubMed bibliographic metadata for PMID 24123422 at 2026-07-30T21:57:02.024Z. PubMed recorded a metadata revision date of 2013-10-23 and an Entrez history date of 2013-10-15. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-24123422-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-10-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24123422-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-24123422-pramlintide-v1
- Content SHA-256: `0d78ca516dfd1a757b6f7fb9a027cc2a2999f2d802c075f2f0b0617577c2e3c9`

### Claims and source pins

#### Headline

PubMed record PMID 24123422 ([`pubmed-observation-pmid-24123422-2013-10-23-143ec173d750`](#source-pubmed-observation-pmid-24123422-2013-10-23-143ec173d750))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 24123422 at 2026-07-30T21:57:02.024Z. PubMed recorded a metadata revision date of 2013-10-23 and an Entrez history date of 2013-10-15. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-24123422-2013-10-23-143ec173d750`](#source-pubmed-observation-pmid-24123422-2013-10-23-143ec173d750))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 24123422 at 2026-07-30T21:57:02.024Z. PubMed recorded a metadata revision date of 2013-10-23 and an Entrez history date of 2013-10-15. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-24123422-2013-10-23-143ec173d750`](#source-pubmed-observation-pmid-24123422-2013-10-23-143ec173d750))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24123422-2013-10-23-143ec173d750`](#source-pubmed-observation-pmid-24123422-2013-10-23-143ec173d750))

### Sources

<a id="source-pubmed-observation-pmid-24123422-2013-10-23-143ec173d750"></a>
- **PubMed record PMID 24123422 · retained source version 1:2013-10-23:current:143ec173d750f2eac054bf55716c5ab819a578154a11fe87595e9655064d88e0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24123422/) (`pubmed-observation-pmid-24123422-2013-10-23-143ec173d750`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 24123422." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-24123422-pramlintide-v1 SHA-256: 0d78ca516dfd1a757b6f7fb9a027cc2a2999f2d802c075f2f0b0617577c2e3c9.

---

<a id="pubmed-pmid-24169554-pramlintide-v1"></a>

## Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.

> PubMed lists PMID 24169554 in Endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-12-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24169554-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-03-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24169554-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-24169554-pramlintide-v1
- Content SHA-256: `81b85fa145d356e7e2a19470712be343f7dfdb32cea2d512fefd4d61c8c101d9`

### Claims and source pins

#### Headline

Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors. ([`pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d`](#source-pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d))

#### Summary

PubMed lists PMID 24169554 in Endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-12-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d`](#source-pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d))

#### Paragraph 1

PubMed lists PMID 24169554 in Endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-12-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d`](#source-pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d`](#source-pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d))

### Sources

<a id="source-pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d"></a>
- **Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors. · retained source version 1:2022-03-16:current:ecac09149a1d6a5bbbd4cd2fb1d67a17b9b153dee6a06438e74a15d7c0855045** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24169554/) (`pubmed-observation-pmid-24169554-2022-03-16-ecac09149a1d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-24169554-pramlintide-v1 SHA-256: 81b85fa145d356e7e2a19470712be343f7dfdb32cea2d512fefd4d61c8c101d9.

---

<a id="pubmed-pmid-27665170-pramlintide-v1"></a>

## Amyloidogenesis of the amylin analogue pramlintide.

> PubMed lists PMID 27665170 in Biophysical chemistry as Journal Article, with publication-date metadata of 2016-09-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27665170-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-12-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27665170-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-27665170-pramlintide-v1
- Content SHA-256: `4b01f673c1bbddad481e3ced3fbf24fe11e91907e68726735e23a7b22fe89d82`

### Claims and source pins

#### Headline

Amyloidogenesis of the amylin analogue pramlintide. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

#### Summary

PubMed lists PMID 27665170 in Biophysical chemistry as Journal Article, with publication-date metadata of 2016-09-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

#### Paragraph 1

PubMed lists PMID 27665170 in Biophysical chemistry as Journal Article, with publication-date metadata of 2016-09-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

### Sources

<a id="source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52"></a>
- **Amyloidogenesis of the amylin analogue pramlintide. · retained source version 1:2019-12-10:current:58e631e24d529c3177ec1325eeae8b36f77a2f55bbeb2d5ce405bbcd74b93ef9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27665170/) (`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Amyloidogenesis of the amylin analogue pramlintide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-27665170-pramlintide-v1 SHA-256: 4b01f673c1bbddad481e3ced3fbf24fe11e91907e68726735e23a7b22fe89d82.

---

<a id="pubmed-pmid-28672144-pramlintide-v1"></a>

## Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation.

> PubMed lists PMID 28672144 in Journal of inorganic biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-06-23 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28672144-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-03-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28672144-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-28672144-pramlintide-v1
- Content SHA-256: `fec16a22d9c2abf89de46bdbbb5ffd748f0ea1e2dc72bd3a1413e14ee7aec72f`

### Claims and source pins

#### Headline

Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation. ([`pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948`](#source-pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948))

#### Summary

PubMed lists PMID 28672144 in Journal of inorganic biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-06-23 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948`](#source-pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948))

#### Paragraph 1

PubMed lists PMID 28672144 in Journal of inorganic biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-06-23 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948`](#source-pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948`](#source-pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948))

### Sources

<a id="source-pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948"></a>
- **Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation. · retained source version 1:2018-03-13:current:27ff847eb948d5f6cc9cf5503a0fe911f4be5a1b866dcf7dd2e59f364a6fd8b6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28672144/) (`pubmed-observation-pmid-28672144-2018-03-13-27ff847eb948`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-28672144-pramlintide-v1 SHA-256: fec16a22d9c2abf89de46bdbbb5ffd748f0ea1e2dc72bd3a1413e14ee7aec72f.

---

<a id="pubmed-pmid-29389581-pramlintide-v1"></a>

## Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.

> PubMed lists PMID 29389581 in Journal of food and drug analysis as Journal Article, with publication-date metadata of 2017-08-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29389581-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-08-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29389581-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-29389581-pramlintide-v1
- Content SHA-256: `126d95199684fe6eae962f5907ef242a3a482ec04c13051ff1bb9d88bb3d4c1d`

### Claims and source pins

#### Headline

Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS. ([`pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70`](#source-pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70))

#### Summary

PubMed lists PMID 29389581 in Journal of food and drug analysis as Journal Article, with publication-date metadata of 2017-08-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70`](#source-pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70))

#### Paragraph 1

PubMed lists PMID 29389581 in Journal of food and drug analysis as Journal Article, with publication-date metadata of 2017-08-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70`](#source-pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70`](#source-pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70))

### Sources

<a id="source-pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70"></a>
- **Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS. · retained source version 1:2022-08-09:current:48182ebbcc7015ebe535887f57c06a9ac6b6b1524a644f0869ae918a03bf634f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29389581/) (`pubmed-observation-pmid-29389581-2022-08-09-48182ebbcc70`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS." Version 1, published 2026-08-16. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-29389581-pramlintide-v1 SHA-256: 126d95199684fe6eae962f5907ef242a3a482ec04c13051ff1bb9d88bb3d4c1d.

---

<a id="pubmed-pmid-29928940-pramlintide-v1"></a>

## Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.

> PubMed lists PMID 29928940 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2018-06-19 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29928940-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-12-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29928940-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-29928940-pramlintide-v1
- Content SHA-256: `7ad50805087fe63d997aae4c215644e31a1c0e8866b12ca580017f10721d2d8e`

### Claims and source pins

#### Headline

Physico-chemical properties of co-formulated fast-acting insulin with pramlintide. ([`pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b`](#source-pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b))

#### Summary

PubMed lists PMID 29928940 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2018-06-19 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b`](#source-pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b))

#### Paragraph 1

PubMed lists PMID 29928940 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2018-06-19 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b`](#source-pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b`](#source-pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b))

### Sources

<a id="source-pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b"></a>
- **Physico-chemical properties of co-formulated fast-acting insulin with pramlintide. · retained source version 1:2019-12-10:current:f65dc847364b6c5b46300c0a5ec45dac8188f2502cd71822e77ab236712d0024** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29928940/) (`pubmed-observation-pmid-29928940-2019-12-10-f65dc847364b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Physico-chemical properties of co-formulated fast-acting insulin with pramlintide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-29928940-pramlintide-v1 SHA-256: 7ad50805087fe63d997aae4c215644e31a1c0e8866b12ca580017f10721d2d8e.

---

<a id="pubmed-pmid-36704426-pramlintide-v1"></a>

## Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles.

> PubMed lists PMID 36704426 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2022-10-29 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36704426-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-02-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36704426-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-36704426-pramlintide-v1
- Content SHA-256: `fc2a97f27fc325c07c4d60a70d68a1755d22c22391fc17a5def78ba06ef5d2ec`

### Claims and source pins

#### Headline

Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles. ([`pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab`](#source-pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab))

#### Summary

PubMed lists PMID 36704426 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2022-10-29 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab`](#source-pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab))

#### Paragraph 1

PubMed lists PMID 36704426 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2022-10-29 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab`](#source-pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab`](#source-pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab))

### Sources

<a id="source-pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab"></a>
- **Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles. · retained source version 1:2023-02-02:current:12ccc3e135ab9bea63eacb3ee4426d7a74921c641371ccf2c4c0f2254ada9995** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36704426/) (`pubmed-observation-pmid-36704426-2023-02-02-12ccc3e135ab`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-36704426-pramlintide-v1 SHA-256: fc2a97f27fc325c07c4d60a70d68a1755d22c22391fc17a5def78ba06ef5d2ec.

---

<a id="pubmed-pmid-38906614-pramlintide-v1"></a>

## Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.

> PubMed lists PMID 38906614 in The Lancet. Digital health as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38906614-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38906614-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-38906614-pramlintide-v1
- Content SHA-256: `a1054a4a672f3c465ce715c22207a5041d29e54327291b4c7011fdee140b9638`

### Claims and source pins

#### Headline

Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada. ([`pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45`](#source-pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45))

#### Summary

PubMed lists PMID 38906614 in The Lancet. Digital health as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45`](#source-pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45))

#### Paragraph 1

PubMed lists PMID 38906614 in The Lancet. Digital health as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45`](#source-pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45`](#source-pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45))

### Sources

<a id="source-pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45"></a>
- **Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada. · retained source version 1:2025-05-28:current:a8c145865e45418886dc1496431487575f6060e42a7c9b6422afec70f839e879** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38906614/) (`pubmed-observation-pmid-38906614-2025-05-28-a8c145865e45`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-38906614-pramlintide-v1 SHA-256: a1054a4a672f3c465ce715c22207a5041d29e54327291b4c7011fdee140b9638.

---

<a id="pubmed-pmid-39109464-pramlintide-v1"></a>

## PubMed record PMID 39109464

> PeptideScanner retained PubMed bibliographic metadata for PMID 39109464 at 2026-07-30T16:14:08.819Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2024-08-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39109464-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39109464-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-39109464-pramlintide-v1
- Content SHA-256: `b8f069f1e6b43d068cc8521685af1b075c9b60100ab23dd2eb02314e06df1cea`

### Claims and source pins

#### Headline

PubMed record PMID 39109464 ([`pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926`](#source-pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39109464 at 2026-07-30T16:14:08.819Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2024-08-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926`](#source-pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39109464 at 2026-07-30T16:14:08.819Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2024-08-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926`](#source-pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926`](#source-pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926))

### Sources

<a id="source-pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926"></a>
- **PubMed record PMID 39109464 · retained source version 1:2026-06-04:current:16d73fde1926afc6694e6dbbb7257802f7922abd360f768063f7d8c60a5a1320** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39109464/) (`pubmed-observation-pmid-39109464-2026-06-04-16d73fde1926`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39109464." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-39109464-pramlintide-v1 SHA-256: b8f069f1e6b43d068cc8521685af1b075c9b60100ab23dd2eb02314e06df1cea.

---

<a id="pubmed-pmid-41022243-pramlintide-v1"></a>

## PubMed record PMID 41022243

> PeptideScanner retained PubMed bibliographic metadata for PMID 41022243 at 2026-08-10T18:13:37.942Z. PubMed recorded a metadata revision date of 2026-07-11 and an Entrez history date of 2025-09-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41022243-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-11
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41022243-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-41022243-pramlintide-v1
- Content SHA-256: `db687ec218398b24761700f20a8865bfa7da9ae4d5eed6b4712d24ce20213392`

### Claims and source pins

#### Headline

PubMed record PMID 41022243 ([`pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d`](#source-pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41022243 at 2026-08-10T18:13:37.942Z. PubMed recorded a metadata revision date of 2026-07-11 and an Entrez history date of 2025-09-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d`](#source-pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41022243 at 2026-08-10T18:13:37.942Z. PubMed recorded a metadata revision date of 2026-07-11 and an Entrez history date of 2025-09-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d`](#source-pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d`](#source-pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d))

### Sources

<a id="source-pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d"></a>
- **PubMed record PMID 41022243 · retained source version 1:2026-07-11:current:e9de5f4d008daecaafddd382ba2e4c931b6bfad059bfb6ffdceabadf4fcb1da8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41022243/) (`pubmed-observation-pmid-41022243-2026-07-11-e9de5f4d008d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41022243." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-41022243-pramlintide-v1 SHA-256: db687ec218398b24761700f20a8865bfa7da9ae4d5eed6b4712d24ce20213392.

---

<a id="pubmed-pmid-41174925-pramlintide-v1"></a>

## PubMed record PMID 41174925

> PeptideScanner retained PubMed bibliographic metadata for PMID 41174925 at 2026-08-10T18:13:37.974Z. PubMed recorded a metadata revision date of 2026-07-05 and an Entrez history date of 2025-11-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41174925-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-05
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41174925-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-41174925-pramlintide-v1
- Content SHA-256: `1e56cecfe00fef65847400ed2c16230280656c1da0575ae4bc4ff0b3af491cd0`

### Claims and source pins

#### Headline

PubMed record PMID 41174925 ([`pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46`](#source-pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41174925 at 2026-08-10T18:13:37.974Z. PubMed recorded a metadata revision date of 2026-07-05 and an Entrez history date of 2025-11-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46`](#source-pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41174925 at 2026-08-10T18:13:37.974Z. PubMed recorded a metadata revision date of 2026-07-05 and an Entrez history date of 2025-11-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46`](#source-pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46`](#source-pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46))

### Sources

<a id="source-pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46"></a>
- **PubMed record PMID 41174925 · retained source version 1:2026-07-05:current:ac836d8c0e46436ca2b6930101738bc393ac3e11d34d014de6f007e9e5059f6f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41174925/) (`pubmed-observation-pmid-41174925-2026-07-05-ac836d8c0e46`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41174925." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-41174925-pramlintide-v1 SHA-256: 1e56cecfe00fef65847400ed2c16230280656c1da0575ae4bc4ff0b3af491cd0.

---

<a id="pubmed-pmid-9028722-pramlintide-v1"></a>

## PubMed record PMID 9028722

> PeptideScanner retained PubMed bibliographic metadata for PMID 9028722 at 2026-07-30T21:56:53.316Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-01-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9028722-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9028722-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9028722-pramlintide-v1
- Content SHA-256: `9059e3ae278ffb13fa8ebad44272871e23946b8ffabffe47a4b51a369fa69d67`

### Claims and source pins

#### Headline

PubMed record PMID 9028722 ([`pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8`](#source-pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9028722 at 2026-07-30T21:56:53.316Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-01-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8`](#source-pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9028722 at 2026-07-30T21:56:53.316Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-01-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8`](#source-pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8`](#source-pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8))

### Sources

<a id="source-pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8"></a>
- **PubMed record PMID 9028722 · retained source version 1:2013-11-25:current:a89d7e69c1f81bf03af429f9e3287b6371caeff0e4395d252340b681955d961a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9028722/) (`pubmed-observation-pmid-9028722-2013-11-25-a89d7e69c1f8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9028722." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9028722-pramlintide-v1 SHA-256: 9059e3ae278ffb13fa8ebad44272871e23946b8ffabffe47a4b51a369fa69d67.

---

<a id="pubmed-pmid-9147903-pramlintide-v1"></a>

## PubMed record PMID 9147903

> PeptideScanner retained PubMed bibliographic metadata for PMID 9147903 at 2026-07-30T21:56:53.319Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-04-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9147903-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9147903-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9147903-pramlintide-v1
- Content SHA-256: `69ada97e98553386cc761788e0fa3ab3a92e923fabfccd639b70998564cfba08`

### Claims and source pins

#### Headline

PubMed record PMID 9147903 ([`pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6`](#source-pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9147903 at 2026-07-30T21:56:53.319Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-04-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6`](#source-pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9147903 at 2026-07-30T21:56:53.319Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-04-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6`](#source-pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6`](#source-pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6))

### Sources

<a id="source-pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6"></a>
- **PubMed record PMID 9147903 · retained source version 1:2013-11-25:current:3b049295eef6aea7b62ff2e547f90ea8c2247ffda64a5f841a48dfdea3f6bf46** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9147903/) (`pubmed-observation-pmid-9147903-2013-11-25-3b049295eef6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9147903." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9147903-pramlintide-v1 SHA-256: 69ada97e98553386cc761788e0fa3ab3a92e923fabfccd639b70998564cfba08.

---

<a id="pubmed-pmid-9223392-pramlintide-v1"></a>

## PubMed record PMID 9223392

> PeptideScanner retained PubMed bibliographic metadata for PMID 9223392 at 2026-07-30T21:56:54.170Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-07-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9223392-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9223392-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9223392-pramlintide-v1
- Content SHA-256: `ad01d2262f59bf133a5ac3b801a438b70cfc8798c508caaf7c9e628b0e92f59c`

### Claims and source pins

#### Headline

PubMed record PMID 9223392 ([`pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84`](#source-pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9223392 at 2026-07-30T21:56:54.170Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-07-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84`](#source-pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9223392 at 2026-07-30T21:56:54.170Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-07-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84`](#source-pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84`](#source-pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84))

### Sources

<a id="source-pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84"></a>
- **PubMed record PMID 9223392 · retained source version 1:2013-11-25:current:9b662a23bc8494a7b749b5188d4a7fe63bb8b88f4d556002e228b5849d9add48** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9223392/) (`pubmed-observation-pmid-9223392-2013-11-25-9b662a23bc84`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9223392." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9223392-pramlintide-v1 SHA-256: ad01d2262f59bf133a5ac3b801a438b70cfc8798c508caaf7c9e628b0e92f59c.

---

<a id="pubmed-pmid-9587964-pramlintide-v1"></a>

## Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.

> PubMed lists PMID 9587964 in Pharmaceutical research as Journal Article, with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-9587964-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-08-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9587964-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9587964-pramlintide-v1
- Content SHA-256: `ec626bd337037d4922a37aa011bb152492ac994341f9ea35e07f30e0b6dc8a40`

### Claims and source pins

#### Headline

Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product. ([`pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad`](#source-pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad))

#### Summary

PubMed lists PMID 9587964 in Pharmaceutical research as Journal Article, with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad`](#source-pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad))

#### Paragraph 1

PubMed lists PMID 9587964 in Pharmaceutical research as Journal Article, with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad`](#source-pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad`](#source-pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad))

### Sources

<a id="source-pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad"></a>
- **Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product. · retained source version 1:2019-08-18:current:e582d7aa50ad6702caeaad352eb1acb2395e892fa31409633d48698b2bfee325** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9587964/) (`pubmed-observation-pmid-9587964-2019-08-18-e582d7aa50ad`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9587964-pramlintide-v1 SHA-256: ec626bd337037d4922a37aa011bb152492ac994341f9ea35e07f30e0b6dc8a40.

---

<a id="pubmed-pmid-9628276-pramlintide-v1"></a>

## PubMed record PMID 9628276

> PeptideScanner retained PubMed bibliographic metadata for PMID 9628276 at 2026-07-30T21:56:54.177Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-06-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9628276-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9628276-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9628276-pramlintide-v1
- Content SHA-256: `b69d962170d583d585bf186d66a98bd0d801593abc0edd7907445367571d187d`

### Claims and source pins

#### Headline

PubMed record PMID 9628276 ([`pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860`](#source-pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9628276 at 2026-07-30T21:56:54.177Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-06-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860`](#source-pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9628276 at 2026-07-30T21:56:54.177Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-06-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860`](#source-pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860`](#source-pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860))

### Sources

<a id="source-pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860"></a>
- **PubMed record PMID 9628276 · retained source version 1:2013-11-25:current:9c24a9cfc86035f89332b81db032fd5b9feed72943ee9b736c4b2034d30b8277** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9628276/) (`pubmed-observation-pmid-9628276-2013-11-25-9c24a9cfc860`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9628276." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9628276-pramlintide-v1 SHA-256: b69d962170d583d585bf186d66a98bd0d801593abc0edd7907445367571d187d.

---

<a id="pubmed-pmid-9761382-pramlintide-v1"></a>

## PubMed record PMID 9761382

> PeptideScanner retained PubMed bibliographic metadata for PMID 9761382 at 2026-07-30T21:56:54.179Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-10-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9761382-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9761382-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9761382-pramlintide-v1
- Content SHA-256: `ef038e1a4b241afb400719c35b22d881167c76d3d2620b1b8e27c9601262051a`

### Claims and source pins

#### Headline

PubMed record PMID 9761382 ([`pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b`](#source-pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9761382 at 2026-07-30T21:56:54.179Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-10-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b`](#source-pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9761382 at 2026-07-30T21:56:54.179Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-10-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b`](#source-pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b`](#source-pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b))

### Sources

<a id="source-pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b"></a>
- **PubMed record PMID 9761382 · retained source version 1:2013-11-25:current:e2c7ba77a01b04a46529dfe9aa1026ef3de5eccccaee1f1c65eb9e4ae3e03d60** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9761382/) (`pubmed-observation-pmid-9761382-2013-11-25-e2c7ba77a01b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9761382." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/pramlintide.json#pubmed-pmid-9761382-pramlintide-v1 SHA-256: ef038e1a4b241afb400719c35b22d881167c76d3d2620b1b8e27c9601262051a.

